Providing market intelligence for more than 35 years

In The News

mHealth Still Missing the Comfort Zone for Chronic Care Patients

A report from digital health analyst Parks Associates indicates 27 percent of those surveyed with a chronic condition want a mobile health device that tracks their condition – yet significant numbers also report that the devices they now have are too complicated to use or don’t work properly.

"Nearly one-half of type I diabetics and one-third of type II diabetics are interested in health monitoring devices such as glucometers, but a steep learning curve and difficult or counterintuitive directions could inhibit their usage of these devices and also prevent them from buying other connected health devices," Harry Wang, the group’s senior director of research, said in a press release accompanying the report. "Device and application manufacturers would benefit from improving the ease-of-use of these devices."

The study points to a continuation of missed opportunities in mHealth for both patients and their caregivers. 

From the article "mHealth Still Missing the Comfort Zone for Chronic Care Patients" by Eric Wicklund.

Previously In The News

Startup Talk: AT&T Joins Verizon With Announcement Of 5G Network Roadmap, Speeds 100x Faster

Dallas-based marketing research firm Parks Associates has released new mobile research showing 86% of U.S. broadband households now own a smartphone. The smartphone markets in European nations, like i...

Artificial Intelligence + Algorithms = Assumptions!

The public is awakening to this new threat of big data as “Big Brother” while acknowledging all its potential benefits. We do not need many of the idiocies promoted for profit in the Internet of Thing...

Prediction: Wi-Fi-Cell Hybrid Service Is Coming

As always, timing is everything. Research published in July by Parks Associates suggests U.S. mobile carriers are shifting their focus from ARPU growth to churn management as new smartphone users beco...

TTA’s Week: Digital Health Funding, Execs’ Wish List, ActivePreventive Responds…And Theranos

We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...